Bormioli Pharma inaugurated a new furnace and production lines yesterday (Tuesday) at its San Vito al Tagliamento plant in North-Eastern Italy.
The €20 million investment will allow, when fully operational, the increase of production capacity from 30t/day to 110t/day.
There is also possibility to add a third production line to extend the plant’s capacity to 150t/day.
A number of dignitaries from the local region joined Bormioli Pharma CEO, Andrea Lodetti (pictured), and senior staff to officially open the new plant.
A video of the new plant is available from here
The revamped and expanded plant features cutting-edge technologies in different areas of the glassmaking process.
It was designed to ensure a high operational flexibility and to allow to operate with different formats and production technologies.
In addition to high standards of energy efficiency, the plant now features a system of prevention and safety as well as an emission control mechanism of absolute excellence.
The pharmaceutical glassmaker implemented a plan to hire new resources, which resulted in an increase of about 50% in the workforce.
This enabled the company to hire about 50 workers, who have already been involved in glass manufacturing training sessions.
Mr Lodetti said: “The decision to invest in the renovation and development of our plant in San Vito responds to the company's growth plans and the need to improve our level of service, further reducing lead times and ensuring product availability even during periods of periodic maintenance of our production site in Bergantino.
“The construction of this plant further confirms the company's ability to improve continuously, through the integration and development of its technological skills on production processes.”
Bormioli Pharma recently acquired German company Remy & Geiser which specialises in closure and dosing systems as well as tubular glass vials.
Bormioli Pharma is based in Parma, Italy and was acquired by Triton financial investment group in November 2017.
The company produces about 5.5 billion pieces a year and employs about 900 people, 120 of which – when fully operational – are based in San Vito al Tagliamento plant.
21.11.2019, Bormioli Pharma/Glass International
News material on the Site is copyright and belongs to the Company or to its third party news provider, and all rights are reserved. Any User who accesses such material may do so only for its own personal use, and the use of such material is at the sole risk of the User. Redistribution or other commercial exploitation of such news material is expressly prohibited. Where such news material is provided by a third party, each User agrees to observe and be bound by the specific terms of use applying to such news material. We do not represent or endorse the accuracy or reliability of any of the info contained in any news or external websites referred to in the news.
Should the content or the design of these sites violate third parties rights or legal prescriptions, we kindly ask you to send us a respective message without invoice or cost. We guarantee that passages where the claim is considered as justified will be removed immediately, without any necessity to involve any lawyer into this issue. We will reject any claim caused by submission of a honorary note in this regard without any prior contact and confirmation of the issueby us and we reserve the right ssue counter claim ourselves because of violation of aforesaid conditions.